Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2020 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference

PARSIPPANY, N.J., May 13, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference at...
May 07, 2020 08:00 ET | Source: Pacira BioSciences

Pacira BioSciences Reports First Quarter 2020 Financial Results and Business Update

-- Total revenues increased 16 percent over prior year first quarter ---- Conference call today at 8:30 a.m. ET -- PARSIPPANY, N.J., May 07, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc....
May 04, 2020 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences Appoints Donald C. Manning, M.D., Ph.D. as Chief Medical Officer

-- Veteran Industry Executive and Anesthesiologist Brings Significant Clinical and Commercial Experience in Pain Management -- PARSIPPANY, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences,...
April 30, 2020 07:30 ET | Source: Pacira BioSciences

Pacira to Report First Quarter 2020 Financial Results on Thursday May 7, 2020

PARSIPPANY, N.J., April 30, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S....
March 09, 2020 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences to Present at the 2020 Barclays Global Healthcare Conference

PARSIPPANY, N.J., March 09, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 2020 Barclays Global Healthcare Conference at 9:00 AM ET on...
February 20, 2020 08:00 ET | Source: Pacira BioSciences

Pacira Reports Record Fourth Quarter and Full-Year Revenues

— Full-year 2019 revenue increases 25 percent to $421 million versus 2018 —— Total 2020 revenue guidance of between $485 million and $500 million —— Anesthesia-driven regional approaches are expanding...
February 13, 2020 07:30 ET | Source: Pacira BioSciences

Pacira to Report 2019 Financial Results on Thursday February 20, 2020

PARSIPPANY, N.J., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its fourth quarter and year ended December 31, 2019 financial results...
January 21, 2020 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences Launches National Regional Anesthesia Training Initiative with Envision Physician Services

PARSIPPANY, N.J., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), a leading provider of innovative non-opioid pain management options, today announced a collaboration with...
January 09, 2020 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences Reports Full-Year 2019 Preliminary Revenue of $421.0 Million

PARSIPPANY, N.J., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), a leading provider of innovative non-opioid pain management options, today reported preliminary unaudited...
January 08, 2020 07:30 ET | Source: Pacira BioSciences

Pacira BioSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 38th Annual J.P. Morgan Healthcare Conference at 9:30 AM PT...